ESC 2022 - PACE-CME

Episodes 17-23 of 23

Combination therapy with loop diuretic and acetazolamide improves decongestion in acute HF
Combination therapy with loop diuretic and acetazolamide improves decongestion in acute HF
ESC 2022
Combination therapy with loop diuretic and acetazolamide improves decongestion in acute HF
- Prof. Wilfried Mullens, MD, PhD
Prediction of life expectancy and life years gained by medication in HFrEF
Prediction of life expectancy and life years gained by medication in HFrEF
ESC 2022
Prediction of life expectancy and life years gained by medication in HFrEF
- Stefan Koudstaal, MD, PhD
All patients with HF regardless of EF benefit from SGLT2i
All patients with HF regardless of EF benefit from SGLT2i
ESC 2022
All patients with HF regardless of EF benefit from SGLT2i
- Pardeep Jhund, MD, PhD
SGLT2i improves outcomes in HFpEF and HFmrEF
SGLT2i improves outcomes in HFpEF and HFmrEF
ESC 2022
SGLT2i improves outcomes in HFpEF and HFmrEF
- Scott Solomon, MD
Totality of evidence of SGLT2 inhibition in HF
Totality of evidence of SGLT2 inhibition in HF
ESC 2022
Totality of evidence of SGLT2 inhibition in HF
- Muthiah Vaduganathan, MD
Cognitive function not affected by ARNI
Cognitive function not affected by ARNI
ESC 2022
Cognitive function not affected by ARNI
- Prof. John McMurray, MD
A polypill for secondary prevention in post-MI patients
A polypill for secondary prevention in post-MI patients
ESC 2022
A polypill for secondary prevention in post-MI patients
- Valentin Fuster, MD, PhD

Previous
1
2
Next

2/2